JFL Life Sciences Ltd | Industry : Pharmaceuticals | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar'2025 | Mar'2024 | Mar'2023 | Mar'2022 | Mar'2021 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 33.00 | 11.00 | 11.00 | 8.02 | 0.50 |
Reserves | 6.46 | 24.58 | 21.27 | 3.27 | 6.38 |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 39.46 | 35.58 | 32.27 | 11.29 | 6.88 |
Secured Loans | 10.36 | 5.69 | 7.18 | 13.53 | 12.91 |
Unsecured Loans | 0.23 | 0.00 | 0.00 | 2.32 | 3.91 |
Total Debt | 10.59 | 5.69 | 7.18 | 15.85 | 16.82 |
Other Liabilities | 0.13 | 0.10 | 0.09 | 0.00 | 0.06 |
Total Liabilities | 50.18 | 41.37 | 39.54 | 27.14 | 23.76 |
APPLICATION OF FUNDS : | |||||
Gross Block | 13.83 | 13.08 | 8.92 | 8.81 | 7.79 |
Less: Accumulated Depreciation | 1.59 | 0.60 | 2.12 | 1.68 | 1.28 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 12.24 | 12.48 | 6.80 | 7.13 | 6.51 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Current Assets, Loans & Advances | |||||
Inventories | 23.24 | 15.83 | 12.72 | 14.96 | 5.74 |
Sundry Debtors | 34.95 | 25.85 | 22.48 | 19.80 | 11.81 |
Cash and Bank Balance | 0.06 | 0.44 | 0.06 | 0.19 | 0.04 |
Loans and Advances | 1.25 | 1.48 | 5.88 | 4.35 | 2.88 |
Total Current Assets | 59.50 | 43.60 | 41.14 | 39.30 | 20.45 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 19.15 | 13.60 | 8.37 | 19.79 | 4.92 |
Provisions | 2.27 | 1.74 | 0.96 | 1.15 | 0.20 |
Total CL & Provisions | 21.41 | 15.34 | 9.33 | 20.94 | 5.13 |
Net Current Assets | 38.09 | 28.27 | 31.80 | 18.36 | 15.33 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 0.04 | 0.12 | 0.03 | 0.03 | 0.02 |
Deferred Tax Liability | 0.36 | 0.00 | 0.21 | 0.21 | 0.15 |
Net Deferred Tax | -0.32 | 0.12 | -0.18 | -0.18 | -0.13 |
Other Assets | 0.17 | 0.51 | 1.11 | 1.83 | 2.05 |
Total Assets | 50.18 | 41.37 | 39.53 | 27.14 | 23.75 |
Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |